
BD invests €4 million into a new R&D facility and €30 million in a manufacturing facility
BD (Becton, Dickinson, and Company) is a leading global medical technology company that focuses on advancing healthcare through improved medical
Your portal to stay connected with the pharma and biopharma industry
Discover the latest developments in innovative packaging, drug delivery, manufacturing and filling & assembling.
BD (Becton, Dickinson, and Company) is a leading global medical technology company that focuses on advancing healthcare through improved medical
The biopharmaceutical company Lexicon, have announced the approval of their drug INPEFA™ (sotagliflozin) by the FDA in effort to treatment
A select assortment of Bristol Myers Squibb’s medicines are headed into orbit where researchers will study the crystallization of the biotherapeutics in microgravity.
Moody’s thinks there is potential for Big Pharma acquisitions representing 10% or more of the acquirer’s market cap.
Dive into innovation, sustainability, the latest trends as well as, keeping up with business.
BD (Becton, Dickinson, and Company) is a leading global medical technology company that focuses on advancing healthcare through improved medical
With just two weeks to go until Connect in Pharma 2023, we sat down with event co-founder Wilfried Phipps to discuss the many features and opportunities attendees can look forward to on 14th-15th June. Wilfried shares his insights into the key themes of the conference agenda and gives his advice about how you can make the most out of your visit.
The biopharmaceutical company Lexicon, have announced the approval of their drug INPEFA™ (sotagliflozin) by the FDA in effort to treatment
Connected health will be one of the topics discussed during the upcoming Connect in Pharma conferences. As experts in this sector, Eric Dessertenne, CEO of Biocorp, and Emre Ozcan, Global Head of Digital Health at Merck, will deliver talks on the challenges that lie ahead in the development of connected devices.
Hear from us! Stay connected with updates about the Connect in Pharma event.
With just two weeks to go until Connect in Pharma 2023, we sat down with event co-founder Wilfried Phipps to discuss the many features and opportunities attendees can look forward to on 14th-15th June. Wilfried shares his insights into the key themes of the conference agenda and gives his advice about how you can make the most out of your visit.
Geneva’s position as a leading European life science hub makes it the ideal choice for Connect in Pharma
Finalists showcase innovations in sustainable pharmaceutical packaging, with winners to be announced at Connect in Pharma London, UK, 25 May
Connect in Pharma announce today that for every visitor to the 2023 Geneva-based event, five Swiss francs will be donated
Geneva’s position as a leading European life science hub makes it the ideal choice for Connect in Pharma
Finalists showcase innovations in sustainable pharmaceutical packaging, with winners to be announced at Connect in Pharma London, UK, 25 May
Connect in Pharma announce today that for every visitor to the 2023 Geneva-based event, five Swiss francs will be donated
Connect in Pharma is promoting a new era of cross-sector collaboration within the pharmaceutical industry London, UK, 18 April 2023